Related content

Targeting the mTOR pathway using deforolimus in cancer therapy

By Mahalingam Devalingam   Sankhala Kamalesh   Mita Alain   Giles Francis J   Mita Monica M  

Future Oncology, Vol. 5, Iss. 3, 2009-04 ,pp. : 291-303

Future Medicine

Access to resources Recommend Favorite

NRSF/REST regulates the mTOR signaling pathway in oral cancer cells

By  

Oncology Reports, Vol. 33, Iss. 3, 2015-01 ,pp. : 1459-1464

Spandidos Publications

Access to resources Recommend Favorite

Significance of mTOR Signaling and Its Inhibitor Against Cancer Stem-Like Cells in Colorectal Cancer

By Cai Zerong   Ke Jia   He Xiaosheng   Yuan Ruixue   Chen Yufeng   Wu Xianrui   Wang Lei   Wang Jianping   Lan Ping   Wu Xiaojian  

Annals of Surgical Oncology, Vol. 21, Iss. 1, 2014-01 ,pp. : 179-188

Springer Publishing Company

Access to resources Recommend Favorite

Downregulation of cancer stem cell properties via mTOR signaling pathway inhibition by rapamycin in nasopharyngeal carcinoma

By                        

International Journal of Oncology, Vol. 47, Iss. 3, 2015-01 ,pp. : 909-917

Spandidos Publications

Access to resources Recommend Favorite

Activation of the mTOR signaling pathway in breast cancer MCF7 cells by a peptide derived from Porphyra yezoensis

By  

Oncology Reports, Vol. 33, Iss. 1, 2015-01 ,pp. : 19-24

Spandidos Publications

Access to resources Recommend Favorite